// company-profile

UNITED THERAPEUTICS Corp

UTHR
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings515Insiders17
// api This UNITED THERAPEUTICS Corp insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).

// 90-day insight

Over the last 90 days, UNITED THERAPEUTICS Corp insiders filed 50 Form 4 transactions, none of which were open-market purchases or sales.

  • Most active insider: ROTHBLATT MARTINE A with 21 transactions totaling $10.7M.
  • Largest single sale: $1.6M by EDGEMOND JAMES on Jun 18, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of UNITED THERAPEUTICS Corp as of 2026-03-31

↑ increasing
Total reported AUM
$23.63B
QoQ change
+35.7%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$1.71B
2.9M shares
#2
Avoro Capital Advisors LLC
CIK 1633313
$1.56B
2.6M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$1.16B
2.0M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026EDGEMOND JAMESUTHR
Sale10b5
115$547.81$63K
Jun 18, 2026MAHON PAUL AUTHR
Sale10b5
958$538.03$515K
Jun 18, 2026EDGEMOND JAMESUTHR
Sale10b5
40$545.19$22K
Jun 18, 2026EDGEMOND JAMESUTHR
Sale10b5
265$547.37$145K
Jun 18, 2026MAHON PAUL AUTHR
Sale10b5
160$541.95$87K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.